Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1996
10/31/1996WO1996034107A2 Antiviral proteins, dna coding sequences therefor, and uses thereof
10/31/1996WO1996034106A1 Decorin binding protein compositions and methods of use
10/31/1996WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
10/31/1996WO1996034100A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996WO1996034099A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996033746A1 Treatment of tumors with cells expressing interferons, tumor necrosis factors, or other cytokines
10/31/1996WO1996033734A1 A pluripotent vaccine against enveloped viruses
10/31/1996WO1996027663A3 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells
10/31/1996WO1996017627A3 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells
10/31/1996WO1996013597A3 Improved adenovirus and methods of use thereof
10/31/1996DE19516673A1 Vaccines against human, pref. mucin expressing, tumours
10/31/1996CA2219996A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996CA2219339A1 A pluripotent vaccine against enveloped viruses
10/31/1996CA2219221A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
10/31/1996CA2219214A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
10/31/1996CA2219105A1 Cyanovirin-n, an anti-hiv protein, dna coding sequences therefor, and uses thereof
10/31/1996CA2218492A1 Decorin binding protein compositions and methods of use
10/31/1996CA2214029A1 Single-vial formulations of dna/lipid complexes
10/30/1996EP0739415A1 Anti-hepatitis b poly- and oligonucleotides
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0592476B1 Use of interleukine 10 to produce drugs with a tumour-inhibiting action
10/30/1996CN1134704A Drug binding protein
10/30/1996CN1134460A HTFIIIA gent
10/24/1996WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996WO1996033281A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996WO1996033280A1 An adenovirus helper-virus system
10/24/1996WO1996033271A2 Genetic markers for breast and ovarian cancer
10/24/1996WO1996033268A1 Apopain
10/24/1996WO1996033220A1 Protective helicobacter antigens
10/24/1996WO1996033219A1 Monoclonal antibodies against hiv-1 and vaccines made thereof
10/24/1996WO1996032966A1 Arteriovenous and venous graft treatments: methods and compositions
10/24/1996WO1996032964A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
10/24/1996WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996WO1996032932A1 Dna vaccines against rotavirus infections
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996WO1996027128A3 Hiv determinants required for in vivo replication
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218679A1 Apopain
10/24/1996CA2218610A1 An adenovirus helper-virus system
10/24/1996CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996CA2217496A1 Protective helicobacter antigens
10/24/1996CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions
10/23/1996EP0738328A1 Composition containing nucleic acids, preparation and uses
10/23/1996EP0738327A1 Host-vector system for use in gene therapy
10/23/1996EP0738281A1 Peptides and methods against psoriasis
10/23/1996EP0738155A1 Modular design and synthesis of oxazolone-derived molecules
10/23/1996EP0640143A4 Senescent cell derived inhibitors of dna synthesis.
10/23/1996CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
10/17/1996WO1996032489A1 Glucose-inducible recombinant viral vector
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032483A1 Immune-evading proteins
10/17/1996WO1996032412A1 PEPTIDE SUPPRESSING IxBα PHOSPHORYLATION
10/17/1996WO1996032140A1 Methods for engineering artificial veto cells
10/17/1996WO1996032139A1 Method for in vivo regulation of cardiac muscle contractility
10/17/1996WO1996032138A1 Methods for treating respiratory disease
10/17/1996WO1996032116A1 Compositions and methods for nucleic acid delivery to the lung
10/17/1996WO1996032102A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996WO1996032087A2 Transgenic fish in the treatment of diabetes
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
10/17/1996WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms
10/17/1996WO1996016173A3 Modified proteinase inhibitors
10/17/1996CA2217977A1 Immune-evading proteins
10/17/1996CA2216858A1 Phospholipase c homolog
10/17/1996CA2215987A1 Glucose-inducible recombinant viral vector
10/17/1996CA2192597A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996CA2191969A1 Transgenic fish in the treatment of diabetes
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737252A1 Gene therapy vector for the treatment of low or defective red blood cell production
10/16/1996EP0737248A1 Gene expression control
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133595A Mutants of the Rb and P53 genes and uses thereof
10/15/1996US5565362 DNA sequences to target proteins to the mammary gland for efficient secretion
10/15/1996US5565334 Enhancer sequence for modulating expression in epithelial cells
10/15/1996US5565321 Isolating nucleic acid, amplifying nucleic acid derived from cd40 ligand gene, determining nucleotide sequence, comparing to standard, determining if protein is expressed which binds cd40
10/10/1996WO1996031613A1 Expression library immunization
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031605A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996WO1996031602A1 Retroviral vectors
10/10/1996WO1996031601A1 Polynucleotide immunogenic agents
10/10/1996WO1996031242A1 RECOMBINANT β-CELL AND USES THEREOF
10/10/1996WO1996031241A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996WO1996021416A3 Methods and compositions for treatment of solid tumors in vivo
10/10/1996WO1996016175A3 Lgmd gene coding for a calcium dependent protease
10/10/1996DE19512463A1 Gene and cDNA encoding human cytokine HCC-1
10/10/1996CA2217697A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996CA2217652A1 Recombinant .beta.-cell and uses thereof
10/10/1996CA2217491A1 Polynucleotide immunogenic agents
10/10/1996CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
10/10/1996CA2217297A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996CA2216092A1 Expression library immunization
10/09/1996EP0736100A1 Recombinant protein production in bovine adenovirus expression vector system
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736002A1 Compound capable of introducing at least one molecule into a cell
10/09/1996EP0735899A1 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages
1 ... 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 ... 870